Open Payments (Physician Payments)

Open Payments (Physician Payments)
Name	Open Payments
Other names	Physician Payments Sunshine Act
Established	2013
Administered by	Centers for Medicare & Medicaid Services
Parent	Department of Health and Human Services
Domain	healthcare transparency

Open Payments (Physician Payments) is a United States federal program that publicly reports financial relationships between pharmaceutical and medical device companies and physicians and teaching hospitals. It implements provisions of the Physician Payments Sunshine Act within the Patient Protection and Affordable Care Act and is administered by the Centers for Medicare & Medicaid Services under the United States Department of Health and Human Services. The program aims to increase transparency about industry influence on clinical practice, medical education, and research.

Overview

Open Payments collects, verifies, and publishes detailed records of transfers of value from applicable manufacturers to covered recipients, making links between companies such as Pfizer, Johnson & Johnson, Medtronic, and clinicians visible to the public. The dataset supports analyses by stakeholders including the American Medical Association, Mayo Clinic, Johns Hopkins Hospital, Harvard Medical School, Stanford University School of Medicine, and news organizations like The New York Times and ProPublica. It intersects with regulatory frameworks overseen by agencies such as the Food and Drug Administration and policy debates in forums like the United States Congress and state legislatures.

History and Legislative Background

Provisions that created Open Payments originated in the Physician Payments Sunshine Act, enacted as part of the Patient Protection and Affordable Care Act passed by the 111th United States Congress and signed by Barack Obama. The statutory mandate followed investigative reporting by outlets such as The New York Times and advocacy by organizations including the American Medical Student Association and Center for Public Integrity. Rulemaking and implementation involved notice-and-comment processes under the Federal Register and interaction with statutes like the Administrative Procedure Act. Early enforcement actions and data releases prompted lawsuits brought by companies and professional groups, invoking courts such as the United States Court of Appeals for the District of Columbia Circuit and the United States District Court for the District of Columbia.

Data Collection and Reporting Methodology

Manufacturers and group purchasing organizations submit annual data to the Centers for Medicare & Medicaid Services via secure portals, following technical specifications and guidance informed by stakeholders including American Hospital Association and Association of American Medical Colleges. Reportable fields include recipient identifiers that map to databases like the National Plan and Provider Enumeration System and the National Provider Identifier. Data verification involves attestation, dispute resolution with recipients including physicians affiliated with institutions such as Cleveland Clinic and Massachusetts General Hospital, and publication after adjudication. Methodology updates have referenced standards from organizations such as the Office of Inspector General (United States) and the Government Accountability Office.

Types of Reported Payments and Financial Relationships

The program categorizes transactions into types like general payments, research payments, and ownership or investment interests. Reportable general payments include consulting fees, honoraria, travel and lodging, meals provided at conferences like American Society of Clinical Oncology meetings, and education support for events such as HIMSS Global Health Conference. Research payments report funding associated with clinical trials sponsored by companies like Novartis and GlaxoSmithKline and linked to investigator-initiated trials at centers like MD Anderson Cancer Center. Ownership interests capture equity or stock options in firms including startups funded by venture capital firms and medical device companies like Boston Scientific.

Data Access, Search Tools, and Transparency Use

Open Payments data is accessible through public dashboards maintained by the Centers for Medicare & Medicaid Services, downloadable bulk files, and APIs used by researchers at institutions such as Columbia University, University of California, San Francisco, and Yale School of Public Health. Third-party tools and investigative projects developed by groups like ProPublica and Kaiser Health News enable longitudinal analyses and visualization. Journalists from Reuters, The Washington Post, and Bloomberg News have used the dataset to examine patterns of payments tied to drugs approved by the Food and Drug Administration and guideline committees convened by professional societies such as the American College of Physicians.

Impact, Criticism, and Legal Challenges

Open Payments has influenced research on conflicts of interest published in journals like JAMA, The Lancet, and The New England Journal of Medicine and has informed policy discussions at bodies including the National Academies of Sciences, Engineering, and Medicine. Critics—ranging from physician groups including the American Medical Association to manufacturers represented by trade associations such as PhRMA—have argued about data accuracy, context for industry relationships, and administrative burden. Litigation has raised First Amendment and statutory challenges in courts such as the United States Court of Appeals for the Ninth Circuit and led to negotiated settlements and regulatory clarifications. Academic studies by researchers at Harvard School of Public Health and University of Michigan have quantified associations between payments and prescribing patterns.

Compliance, Enforcement, and Penalties

Compliance requires timely, complete reporting by applicable manufacturers and group purchasing organizations; failures can trigger civil monetary penalties administered by the Centers for Medicare & Medicaid Services under statutory authority and procedures derived from statutes like the Social Security Act. Enforcement actions consider factors involving audits, self-disclosure, corrective action plans, and negotiation with legal counsel from firms practicing healthcare law in venues including the United States District Court for the Eastern District of Virginia. Penalties and policy guidance have evolved through interaction with regulators such as the Office of Inspector General (United States) and oversight by the Congressional Budget Office and Government Accountability Office.

Category:Health policy